Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
38.65
-0.46 (-1.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bright Minds Biosciences Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -3.58 | -7.37 | -14.96 | -8.65 | -0.48 | -0.24 |
| Depreciation & Amortization | 0.07 | 0.07 | 0.01 | - | - | - |
| Asset Writedown & Restructuring Costs | - | - | 0 | - | - | - |
| Stock-Based Compensation | 1.03 | 1.15 | 0.9 | 0.88 | 0.16 | - |
| Other Operating Activities | 0.2 | 0.07 | -0.26 | 0.14 | - | - |
| Change in Accounts Payable | -0.48 | -1.2 | 0.77 | 0.51 | 0.11 | 0.11 |
| Change in Other Net Operating Assets | 0.17 | 0.26 | -0.04 | -0.2 | -0.08 | - |
| Operating Cash Flow | -2.58 | -7.02 | -13.59 | -7.32 | -0.29 | -0.13 |
| Long-Term Debt Repaid | - | -0.09 | -0.01 | - | - | - |
| Net Debt Issued (Repaid) | -0.09 | -0.09 | -0.01 | - | - | - |
| Issuance of Common Stock | 0.9 | 1.47 | 6 | 27.84 | 1.01 | 0.37 |
| Other Financing Activities | - | 0.8 | -0.8 | -1.79 | - | - |
| Financing Cash Flow | 0.81 | 2.19 | 5.2 | 26.06 | 1.01 | 0.37 |
| Foreign Exchange Rate Adjustments | -0.17 | -0.05 | 0.26 | 0.22 | - | - |
| Net Cash Flow | -1.94 | -4.88 | -8.13 | 18.96 | 0.72 | 0.24 |
| Free Cash Flow | -2.58 | -7.02 | -13.59 | -7.32 | -0.29 | -0.13 |
| Free Cash Flow Per Share | -0.63 | -1.89 | -5.50 | -4.08 | -0.40 | -0.30 |
| Levered Free Cash Flow | -1.34 | -4.22 | -7.58 | -3.85 | -0.1 | - |
| Unlevered Free Cash Flow | -1.33 | -4.22 | -7.58 | -3.85 | -0.1 | - |
| Change in Net Working Capital | 0.31 | 0.94 | -0.72 | -0.29 | -0.04 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.